Model N will cover developing a well-rounded pricing strategy and staying ahead of pricing market trends in two signature sessions. CHICAGO, IL – September 16, 2013 – Model N, Inc. (NYSE: [...]
Model N will cover developing a well-rounded pricing strategy and staying ahead of pricing market trends in two signature sessions.
CHICAGO, IL – September 16, 2013 – Model N, Inc. (NYSE: MODN), a leading revenue management solutions provider to the life science and technology industries, today announced it will present at this week’sMedical Device Strategic Pricing Conference in Chicago, Sept. 16-17. As Medical Device companies prepare for a new healthcare environment, this year’s conference focuses on how industry leaders can build the analytics, leverage the best practices, and utilize the value-based pricing models needed to remain competitive.
Model N Senior Director of Industry Solutions, Gop Rao, will moderate the panel, “Incorporating Cross-Department Knowledge to Create a Well-Rounded Pricing Strategy” (Mon., Sept. 16 at 1:30 – 2:15 p.m. CDT) this afternoon. The panel will feature executives from Wright Medical Technology, Johnson & Johnson Global Surgery and Biomet Orthopedics. The discussion will examine the business case for why and how pricing executives should take a financial viability approach to their pricing strategies while pulling knowledge across departments to strengthen those strategies.
Model N will also lead the presentation, “Utilizing IRP to Stay Ahead of Market Trends” on day two of the conference (Tues., Sept. 17 at 9:15 – 10 a.m. CDT). In this session, Rao will co-present with Model N Senior Director of Global Pricing and Market Access Solutions, Arnaud Grunwald, on how medical device companies, looking to expand their product line globally, can leverage cross border reference pricing when determining the price of those products. Through their review of major European and Asian market trends and reimbursement models, the session will provide attendees with vital information to be considered when determining the pricing strategy for a medical technology distributed on a global level.
“In today’s changing, global healthcare environment, pricing medical technologies has become a uniquely complex undertaking,” said Ken Pulverman, vice president of marketing at Model N. “The Model N team is pleased to contribute to this collaborative platform for advancing the decision making, analytical skills, and overall strategies needed to improve pricing and business results for medical device companies.”
In addition to presenting, Model N will be exhibiting as a silver sponsor at this year’s conference. Model N will also hold a networking dinner tonight at 6:15 p.m. for conference attendees at Ristorante Quartino. Interested parties may RSVP at the Model N booth during the conference or email Wendy Mayerson,firstname.lastname@example.org.
Model N Big Ideas: Global Pricing
Model N for Medical Device Companies
About Model N
Model N is the leader in Revenue Management solutions. Model N helps its customers maximize their revenue and reduce revenue compliance risk by managing every dollar that impacts their top line encompassing contracting, pricing, incentives, and rebates. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and Technology companies in more than 50 countries. Global Customers include: Actavis, Allergan, Atmel, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.
Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.